Can Metabolomics Explain Differences in Drug Response?
How much does our environment influence our health—and what could that mean for precision medicine?
Why does a drug work well for some patients but have little effect on others? Differences in underlying disease biology may hold important clues.
In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains how metabolomics can help researchers understand variability in treatment response. By profiling metabolites and lipids in biological samples, researchers can identify active biochemical pathways and investigate whether a drug targets the pathways driving a patient’s disease.
Watch the video to learn how metabolomics can support drug mechanism research, improve patient stratification, and help advance more personalized approaches to treatment.
Have a Question?
Your privacy is important to us.
We’ll never share your information.